Inventor · disambiguated record
Sung-Ju Moon
Also filed as: MOON SUNG · MOON SUNG-JU
32 granted patents·5 pending applications·800 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
37 records- 0199US8268317B2Camptothecin-binding moiety conjugatesGOVINDAN SERENGULAM V·Filed 2009·Granted Sep 18, 2012·82 cites·34 claims
- 0299US8080250B1Immunoconjugates with an intracellularly-cleavable linkageGOVINDAN SERENGULAM V·Filed 2011·Granted Dec 20, 2011·106 cites·15 claims
- 0399US7999083B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2009·Granted Aug 16, 2011·184 cites·13 claims
- 0499US7591994B2Camptothecin-binding moiety conjugatesIMMUNOMEDICS INC·Filed 2008·Granted Sep 22, 2009·129 cites·14 claims
- 0598US11020489B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2020·Granted Jun 1, 2021·4 cites·16 claims
- 0698US9138485B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2014·Granted Sep 22, 2015·32 cites·15 claims
- 0798US8759496B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2012·Granted Jun 24, 2014·38 cites·16 claims
- 0897US10064957B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2017·Granted Sep 4, 2018·14 cites·24 claims
- 0997US9480756B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2016·Granted Nov 1, 2016·13 cites·28 claims
- 1097US9198978B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2015·Granted Dec 1, 2015·20 cites·16 claims
- 1197US9102735B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2013·Granted Aug 11, 2015·27 cites·15 claims
- 1297US8741300B2Immunoconjugates with an intracellularly-cleavable linkageGOVINDAN SERENGULAM V·Filed 2011·Granted Jun 3, 2014·25 cites·9 claims
- 1396US9345783B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2015·Granted May 24, 2016·12 cites·17 claims
- 1496US9233172B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2015·Granted Jan 12, 2016·12 cites·16 claims
- 1596US8999344B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2014·Granted Apr 7, 2015·19 cites·18 claims
- 1695US8834886B2Camptothecin-binding moiety conjugatesIMMUNOMEDICS INC·Filed 2013·Granted Sep 16, 2014·18 cites·31 claims
- 1795US8617558B2Camptothecin-binding moiety conjugatesGOVINDAN SERENGULAM V·Filed 2012·Granted Dec 31, 2013·12 cites·24 claims
- 1894US10265414B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2018·Granted Apr 23, 2019·6 cites·24 claims
- 1993US9675706B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2016·Granted Jun 13, 2017·6 cites·28 claims
- 2093US8338140B2Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sitesGOVINDAN SERENGULAM V·Filed 2011·Granted Dec 25, 2012·8 cites·15 claims
- 2193US8067006B2Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sitesGOVINDAN SERENGULAM V·Filed 2010·Granted Nov 29, 2011·8 cites·7 claims
- 2292US10561738B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2017·Granted Feb 18, 2020·4 cites·16 claims
- 2391US8889835B2Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sitesIMMUNOMEDICS INC·Filed 2012·Granted Nov 18, 2014·5 cites·16 claims
- 2488USRE48751EImmunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2018·Granted Sep 28, 2021·1 cites·16 claims
- 2588US10322193B1Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2019·Granted Jun 18, 2019·2 cites·23 claims
- 2687US9700634B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2015·Granted Jul 11, 2017·2 cites·16 claims
- 2785US10751422B2Antibody drug conjugates (ADC) that bind to FLT3 proteinsAGENSYS INC·Filed 2016·Granted Aug 25, 2020·4 cites·13 claims
- 2882US9707300B2Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sitesIMMUNOMEDICS INC·Filed 2014·Granted Jul 18, 2017·1 cites·10 claims
- 2981US2021346511A1Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2021·Application pending·0 cites
- 3077US11077201B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·7 claims
- 3173US9974865B2Antibody drug conjugates (ADC) that bind to FLT3 proteinsAGENSYS INC·Filed 2016·Granted May 22, 2018·2 cites·30 claims
- 3263US2025213712A1Antibody drug conjugates comprising camptothecin derivatives and uses thereofINTOCELL INC·Filed 2024·Application pending·0 cites
- 3350US12377294B2Anti-CD3 antibody folate bioconjugates and their usesAMBRX INC·Filed 2019·Granted Aug 5, 2025·0 cites·21 claims
- 3449US2023302150A1Antibody-tlr agonist conjugates, methods and uses thereofAMBRX INC·Filed 2021·Application pending·0 cites
- 3549US2008171067A1Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease SitesIMMUNOMEDICS INC·Filed 2007·Application pending·0 cites
- 3646US6258942B1TADG7: a novel gene expressed in ovarian tumor and uses thereofUNIV ARKANSAS·Filed 1997·Granted Jul 10, 2001·4 cites·8 claims
- 3741US2015218220A1Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymeraseMENDELSOHN BRIAN ALAN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sung-Ju Moon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →